Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines

por Anish, Chakkumkal, Beurret, Michel, Poolman, Jan
Publicado 2021

Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1

por Schumann, Benjamin, Reppe, Katrin, Kaplonek, Paulina, Wahlbrink, Annette, Anish, Chakkumkal, Witzenrath, Martin, Pereira, Claney L., Seeberger, Peter H.
Publicado 2018

Glycan and Protein Analysis of Glycoengineered Bacterial E. coli Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry

por Nicolardi, Simone, Danuser, Renzo, Dotz, Viktoria, Domínguez-Vega, Elena, Al Kaabi, Ali, Beurret, Michel, Anish, Chakkumkal, Wuhrer, Manfred
Publicado 2022

Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans

por Broecker, Felix, Hanske, Jonas, Martin, Christopher E., Baek, Ju Yuel, Wahlbrink, Annette, Wojcik, Felix, Hartmann, Laura, Rademacher, Christoph, Anish, Chakkumkal, Seeberger, Peter H.
Publicado 2016

Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites

por Möginger, Uwe, Resemann, Anja, Martin, Christopher E., Parameswarappa, Sharavathi, Govindan, Subramanian, Wamhoff, Eike-Christian, Broecker, Felix, Suckau, Detlev, Pereira, Claney Lebev, Anish, Chakkumkal, Seeberger, Peter H., Kolarich, Daniel
Publicado 2016